Singh AV, Vyas V, Patil R, Sharma V, Scopelliti PE, Bongiorno G, Podesta A, Lenardi C, Gade WN, Milani P
Disclaimer: This product is intended for research use only and not for human or veterinary use
Complete the consultation form, and our team will help determine if Retatrutide is suitable for you
PT-141 offers a brain-based approach to desire and arousal support
Clin Endocrinology
Of note is that the observed median time to onset of the psychiatric AEs in our analysis of the FAERS data aligned with common gastrointestinal AEs such as nausea and vomiting, which were the most frequently reported within the first 30 days of GLP-1 RA treatment ( In this extensive pharmacovigilance study, we observed a significant association between GLP-1 RAs and eight distinct categories of psychiatric AEs, namely, nervousness, stress, eating disorder, fear of injection, sleep disorder due to general medical conditioninsomnia type, binge eating, fear of eating, and self-induced vomiting
